Satsuma Pharmaceuticals, Inc. Shareholders' Equity
Satsuma Pharmaceuticals, Inc. had Shareholders' Equity of $37.65 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-05-11
- 2023-03-31: Stockholders' Equity Attributable to Parent $37.65M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $46.82M.
- 2022-09-30: Stockholders' Equity Attributable to Parent $68.38M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $72.19M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-03-31 | $37.65M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $46.82M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $68.38M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $72.19M 10-Q · filed 2022-11-03 |
| 2022-03-31 | $86.98M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $101.34M 10-Q · filed 2023-05-11 |
| 2021-09-30 | $115.67M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $127.74M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $138.15M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $71.94M 10-K · filed 2023-03-28 |
| 2020-09-30 | $82.99M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $93.93M 10-Q · filed 2021-11-09 |
| 2020-03-31 | $103.99M 10-Q · filed 2021-11-09 |
| 2019-12-31 | $115.33M 10-K · filed 2022-03-15 |
| 2019-09-30 | $118.12M 10-Q · filed 2020-11-10 |
| 2019-06-30 | -$20.99M 10-Q · filed 2020-11-10 |
| 2019-03-31 | -$14.84M 10-Q · filed 2020-08-11 |
| 2018-12-31 | -$12.13M 10-K · filed 2021-03-25 |
| 2018-09-30 | -$9.82M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$8.27M 10-Q · filed 2019-11-12 |
| 2017-12-31 | -$5.43M 10-K · filed 2020-03-10 |
| 2016-12-31 | -$326.00K 10-K · filed 2020-03-10 |